CBA: Biotech, Life Science Organization in Bay Area, California

12:00-1:00	Registration
1:00–1:10	Welcome Remarks Dr. Sydney Chen, CBA President
1:10–3:15	Plenary Session Conference Chair: Dr. Patty Kiang, VP CBA Co-Chair: Dr. Cheng-Chi Chao
	Perspectives on 30 years in Biotechnology Dr. Kevin Moore, Executive Director, Amgen, Inc. Opportunities and Challenges in the Development of Novel Small Molecule Therapeutics for Oncology Dr. Peter Lamb, CSO and Executive VP Discovery, Exelixis Obstacles to the Commercialization of the First Inhaled Insulin Product, Exubera Dr. John Patton, Founder and CEO, Dance Pharmaceuticals Kaletra: a Second Generation Protease Inhibitor From Abbott Laboratories Dr. Hing Sham, Senior VP, Chemical Sciences, Elan Pharmaceuticals *Landscape and Industry Outlook of In Vitro* Diagnostics** Dr. Jimmy Zhang, Senior VP, Synergenics
3:15–3:40	Intermission
3:40–5:45	Advances in Diagnostics and Biomarkers Co-Chair: Dr. Michelle Chen & Ms. Stella Chiang	New Waves in Therapeutic Drug Development Co-Chair: Dr. Jeng Her & Mr. Andrew Teng
	Translating Gene Expression Patterns into Commercialized Cancer Diagnostics Dr. Douglas Ross, CSO, Clarient Inc. Strategies for Developing Pharmacodynamic and Predictive Biomarkers to Target Cancer Stem Cell Agents Dr. Ann Kapoun, Senior Director Translational Medicine, OncoMed Pharmaceuticals *RNAscope™, a Novel RNA In Situ* Hybridization Platform for Personalized Medicine Dr. Yuling Luo, Founder, President and CEO, Advanced Cell Diagnostics Inc. Introducing a Novel, Semiconductor Chip-Based Platform for DNA Biomarker Discovery and Personalized Medicine Dr. Gary Zweiger, VP, Business Development, BioNanomatrix Inc Panel Discussion**	*Capturing the Value of a Drug Before It Hits the Market* The Changing Ecology of 21st Century Pharmaceutical Research and Development.New Strategies in Drug Development from an Investor's Point of View Dr. Jim Larrick, Managing director, Panorama Research Institute; Director, Life Science Angels and Venture Partner, CMEA Changing Business Model for Changing Times: the Rise of Virtual Innovation Dr. Yiyou Chen, CSO & Co-founder, Crown Biosciences *Generation of Customized Medicines through Molecular Profiling* Conducting Personalized Medicine with the Assistance of Biostatisticians. Dr. Xiaowei Yang, CEO, BayesSoft Next Generation Biology through next Generation DNA Sequencing Dr. Dawei Lin, Director Bioinformatics Core, UC Davis Data-Driven Drug Discovery and Personalized Medicine Mr. Joel Dudley, Bioinformatics Specialist, Butte Lab, Stanford University
6:00–6:45	Networking Mixer and Exhibits
6:45–9:00	Dinner, Keynote and Live Entertainment Keynote: ‘The Great Recession’: How US consumer is reacting to it and the implications for international trade Dr. David Robinson, Haas Business School, UC Berkeley & Santa Clara University Live Entertainment: Lily Xu, Remona Ji, and Melody Wang

Sponsors »